Table 2.
Association of miRNA-495 expression in breast cancer cases with different clinicopathological features.
| Variables | miRNA-495 expression | p value | |
|---|---|---|---|
| Mean | SD | ||
| Relative expression | 0.07 | 0.05 | — |
|
| |||
| Age | |||
| ≤50 years | 0.09 | 0.11 | 0.02 |
| >50 years | 0.04 | 0.02 | |
|
| |||
| Menopause | |||
| Yes | 0.04 | 0.03 | 0.0001 |
| No | 0.12 | 0.12 | |
|
| |||
| Lymph nodes | |||
| Yes | 0.07 | 0.10 | 0.21 |
| No | 0.07 | 0.07 | |
|
| |||
| ER status | |||
| Yes | 0.05 | 0.04 | 0.10 |
| No | 0.09 | 0.10 | |
|
| |||
| PR status | |||
| Yes | 0.05 | 0.05 | 0.11 |
| No | 0.08 | 0.09 | |
|
| |||
| HER2 status | |||
| Yes | 0.05 | 0.04 | 0.49 |
| No | 0.08 | 0.10 | |
|
| |||
| TNM stages | |||
| Early stage (I & II) | 0.12 | 0.11 | 0.02 |
| Advanced stage (III & IV) | 0.05 | 0.03 | |
|
| |||
| Distant metastases | |||
| Yes | 0.04 | 0.02 | 0.27 |
| No | 0.08 | 0.09 | |